首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   8920篇
  免费   533篇
  国内免费   151篇
耳鼻咽喉   126篇
儿科学   178篇
妇产科学   88篇
基础医学   1451篇
口腔科学   159篇
临床医学   760篇
内科学   1885篇
皮肤病学   480篇
神经病学   629篇
特种医学   680篇
外科学   1056篇
综合类   34篇
现状与发展   1篇
一般理论   1篇
预防医学   312篇
眼科学   195篇
药学   882篇
中国医学   143篇
肿瘤学   544篇
  2024年   5篇
  2023年   55篇
  2022年   151篇
  2021年   344篇
  2020年   181篇
  2019年   234篇
  2018年   293篇
  2017年   239篇
  2016年   326篇
  2015年   409篇
  2014年   526篇
  2013年   493篇
  2012年   795篇
  2011年   781篇
  2010年   420篇
  2009年   398篇
  2008年   506篇
  2007年   455篇
  2006年   353篇
  2005年   386篇
  2004年   270篇
  2003年   230篇
  2002年   233篇
  2001年   183篇
  2000年   190篇
  1999年   142篇
  1998年   99篇
  1997年   71篇
  1996年   73篇
  1995年   44篇
  1994年   55篇
  1993年   49篇
  1992年   48篇
  1991年   57篇
  1990年   45篇
  1989年   75篇
  1988年   47篇
  1987年   52篇
  1986年   37篇
  1985年   41篇
  1984年   24篇
  1983年   21篇
  1982年   18篇
  1981年   25篇
  1980年   32篇
  1979年   17篇
  1978年   15篇
  1977年   16篇
  1976年   10篇
  1975年   5篇
排序方式: 共有9604条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.

Background and aims

It is not known whether non alcoholic fatty liver disease (NAFLD) is a risk factor for diabetes in non obese, non centrally-obese subjects. Our aim was to investigate relationships between fatty liver, insulin resistance and a biomarker score for liver fibrosis with incident diabetes at follow up, in subjects who were neither obese nor centrally-obese.

Methods and results

As many as 70,303 subjects with a body mass index (BMI) < 25 kg/m2 and without diabetes were followed up for a maximum of 7.9 years. At baseline, fatty liver was identified by liver ultrasound, insulin resistance (IR) by homeostatic model assessment of insulin resistance (HOMA-IR) ≥2.0, and central obesity by waist circumference (waist circumference ≥90 cm (men) and ≥85 cm (women). The Fibrosis-4 (FIB-4 score) was used to estimate extent of liver fibrosis. Cox proportional hazards models adjusted for confounders were used to estimate hazard ratios (aHRs) for incident diabetes. As many as 852 incident cases of diabetes occurred during follow up (median [IQR] 3.71 [2.03] years). Mean ± SD BMI was 22.8 ± 1.8 and 21.7 ± 2.0 kg/m2 in subjects with and without diabetes at follow up. In subjects without central obesity and with fatty liver, aHRs (95% CI) for incident diabetes at follow up were 2.17 (1.56, 3.03) for men, and 2.86 (1.50,5.46) for women. Similar aHRs for incident diabetes occurred with fatty liver, IR and the highest quartile of FIB-4 combined, in men; and there was a non significant trend toward increased risk in women.

Conclusions

In normal weight, non-centrally obese subjects NAFLD is an independent risk factor for incident diabetes.  相似文献   
7.
ABSTRACT

Genotoxic compounds may be detoxified to non-genotoxic metabolites while many pro-carcinogens require metabolic activation to exert their genotoxicity in vivo. Standard genotoxicity assays were developed and utilized for risk assessment for over 40 years. Most of these assays are conducted in metabolically incompetent rodent or human cell lines. Deficient in normal metabolism and relying on exogenous metabolic activation systems, the current in vitro genotoxicity assays often have yielded high false positive rates, which trigger unnecessary and costly in vivo studies. Metabolically active cells such as hepatocytes have been recognized as a promising cell model in predicting genotoxicity of carcinogens in vivo. In recent years, significant advances in tissue culture and biological technologies provided new opportunities for using hepatocytes in genetic toxicology. This review encompasses published studies (both in vitro and in vivo) using hepatocytes for genotoxicity assessment. Findings from both standard and newly developed genotoxicity assays are summarized. Various liver cell models used for genotoxicity assessment are described, including the potential application of advanced liver cell models such as 3D spheroids, organoids, and engineered hepatocytes. An integrated strategy, that includes the use of human-based cells with enhanced biological relevance and throughput, and applying the quantitative analysis of data, may provide an approach for future genotoxicity risk assessment.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号